ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
18K |
7.0M |
6 |
18/09/24 |
18/09/24 |
ASX - By Stock
|
18K
|
7.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
jsonm
|
384 |
174K |
2 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
384
|
174K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
jsonm
|
11K |
3.4M |
45 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
11K
|
3.4M
|
45
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
5 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.3K
|
413K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
4 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.3K
|
413K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
jsonm
|
384 |
174K |
5 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
384
|
174K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
7 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
1.3K
|
413K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
jsonm
|
384 |
174K |
8 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
174K
|
8
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
jsonm
|
687 |
241K |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
687
|
241K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
jsonm
|
1.0K |
443K |
8 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.0K
|
443K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
jsonm
|
225 |
85K |
33 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
85K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
8 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
1.3K
|
413K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
26 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
1.3K
|
413K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
15 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
1.3K
|
413K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
11 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.3K
|
413K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
jsonm
|
236 |
98K |
7 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
236
|
98K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
1.3K |
413K |
5 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.3K
|
413K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jsonm
|
204 |
81K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
81K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jsonm
|
204 |
81K |
16 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
81K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
943 |
409K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
943
|
409K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
943 |
409K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
943
|
409K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
943 |
409K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
943
|
409K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
943 |
409K |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
943
|
409K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
jsonm
|
549 |
186K |
12 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
549
|
186K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
18K |
7.0M |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
18K
|
7.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
jsonm
|
275 |
129K |
5 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
275
|
129K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
jsonm
|
687 |
241K |
8 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
687
|
241K
|
8
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan appoints US Clinical & Regulatory Heads
|
|
jsonm
|
3 |
2.0K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
3
|
2.0K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
jsonm
|
275 |
129K |
7 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
275
|
129K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
jsonm
|
17 |
15K |
6 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
17
|
15K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
jsonm
|
272 |
107K |
21 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
272
|
107K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
jsonm
|
513 |
135K |
36 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
513
|
135K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
jsonm
|
513 |
135K |
22 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
513
|
135K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
jsonm
|
541 |
121K |
8 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
541
|
121K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
jsonm
|
274 |
124K |
15 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
274
|
124K
|
15
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Follow up to NCCN Guidelines for Breast Cancer ASX Release
|
|
jsonm
|
70 |
26K |
5 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
70
|
26K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
jsonm
|
778 |
284K |
3 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
778
|
284K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
18K |
7.0M |
7 |
10/09/22 |
10/09/22 |
ASX - By Stock
|
18K
|
7.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
jsonm
|
778 |
284K |
2 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
778
|
284K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
jsonm
|
1.5K |
512K |
16 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
1.5K
|
512K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast
|
|
jsonm
|
14 |
7.2K |
25 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
14
|
7.2K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
jsonm
|
484 |
149K |
8 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
484
|
149K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
jsonm
|
484 |
149K |
7 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
484
|
149K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
jsonm
|
484 |
149K |
52 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
484
|
149K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
18K |
7.0M |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
18K
|
7.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
jsonm
|
150 |
55K |
4 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
150
|
55K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
jsonm
|
150 |
55K |
27 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
150
|
55K
|
27
|
|
ASX - By Stock
|
MSB |
The Big Blast
|
|
jsonm
|
0 |
525 |
32 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
0
|
525
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jsonm
|
190 |
63K |
9 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
190
|
63K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
jsonm
|
317 |
75K |
0 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
317
|
75K
|
0
|
|